We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong income characteristics for investors to consider today, March 3rd:
Algonquin Power & Utilities Corp. (AQN - Free Report) : This owner and operator of a portfolio of regulated and non-regulated generation, distribution and transmission utility assets has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.7% over the last 60 days.
Algonquin Power & Utilities Corp. Price and Consensus
This Zacks Rank #2 (Buy) company has a dividend yield of 3.78%, compared with the industry average of 2.75%. Its five-year average dividend yield is 4.67%.
Algonquin Power & Utilities Corp. Dividend Yield (TTM)
Best Buy Co., Inc. (BBY - Free Report) : This retailer of technology products, services, and solutions has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.5% over the last 60 days.
This Zacks Rank #2 (Buy) company has a dividend yield of 2.64%, compared with the industry average of 0.00%. Its five-year average dividend yield is 2.67%.
AllianceBernstein Holding L.P. (AB - Free Report) : This provider of investment management services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.2% over the last 60 days.
AllianceBernstein Holding L.P. Price and Consensus
This Zacks Rank #2 (Buy) company has a dividend yield of 11.18%, compared with the industry average of 2.22%. Its five-year average dividend yield is 8.32%.
Bunge Limited (BG - Free Report) : This agribusiness and food company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.9% over the last 60 days.
This Zacks Rank #2 (Buy) company has a dividend yield of 4.26%, compared with the industry average of 0.00%. Its five-year average dividend yield is 2.66%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Top Ranked Income Stocks to Buy for March 3rd
Here are four stocks with buy rank and strong income characteristics for investors to consider today, March 3rd:
Algonquin Power & Utilities Corp. (AQN - Free Report) : This owner and operator of a portfolio of regulated and non-regulated generation, distribution and transmission utility assets has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.7% over the last 60 days.
Algonquin Power & Utilities Corp. Price and Consensus
Algonquin Power & Utilities Corp. price-consensus-chart | Algonquin Power & Utilities Corp. Quote
This Zacks Rank #2 (Buy) company has a dividend yield of 3.78%, compared with the industry average of 2.75%. Its five-year average dividend yield is 4.67%.
Algonquin Power & Utilities Corp. Dividend Yield (TTM)
Algonquin Power & Utilities Corp. dividend-yield-ttm | Algonquin Power & Utilities Corp. Quote
Best Buy Co., Inc. (BBY - Free Report) : This retailer of technology products, services, and solutions has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.5% over the last 60 days.
Best Buy Co., Inc. Price and Consensus
Best Buy Co., Inc. price-consensus-chart | Best Buy Co., Inc. Quote
This Zacks Rank #2 (Buy) company has a dividend yield of 2.64%, compared with the industry average of 0.00%. Its five-year average dividend yield is 2.67%.
Best Buy Co., Inc. Dividend Yield (TTM)
Best Buy Co., Inc. dividend-yield-ttm | Best Buy Co., Inc. Quote
AllianceBernstein Holding L.P. (AB - Free Report) : This provider of investment management services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.2% over the last 60 days.
AllianceBernstein Holding L.P. Price and Consensus
AllianceBernstein Holding L.P. price-consensus-chart | AllianceBernstein Holding L.P. Quote
This Zacks Rank #2 (Buy) company has a dividend yield of 11.18%, compared with the industry average of 2.22%. Its five-year average dividend yield is 8.32%.
AllianceBernstein Holding L.P. Dividend Yield (TTM)
AllianceBernstein Holding L.P. dividend-yield-ttm | AllianceBernstein Holding L.P. Quote
Bunge Limited (BG - Free Report) : This agribusiness and food company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.9% over the last 60 days.
Bunge Limited Price and Consensus
Bunge Limited price-consensus-chart | Bunge Limited Quote
This Zacks Rank #2 (Buy) company has a dividend yield of 4.26%, compared with the industry average of 0.00%. Its five-year average dividend yield is 2.66%.
Bunge Limited Dividend Yield (TTM)
Bunge Limited dividend-yield-ttm | Bunge Limited Quote
See the full list of top ranked stocks here.
Find more top income stocks with some of our great premium screens.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>